conoGenetix GmbH is a startup based in Germany.
Based in Germany, conoGenetix GmbH is a startup.
conoGenetix GmbH develops peptide-based therapeutics aimed at treating autoimmune diseases such as multiple sclerosis, arthritis and rheumatism. Their approach targets and selectively inhibits the portion of the immune system responsible for the autoimmune response while preserving other immune functions.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.